Search the Newsreel

Guardant Health (NASDAQ: GH) insider files to sell 1,700 shares

Manuel Hidalgo Medina, an insider at Guardant Health (NASDAQ: GH), has filed a Form 144 indicating an intent to sell up to 1,700 shares of common stock through Charles Schwab & Co., Inc. The proposed sale, valued at $279,202.00, is supported by upcoming restricted …

Guardant Health (GH) insider files to sell 1,803,685 shares valued at $134M

An insider at Guardant Health (GH), Meghan V. Joyce, has filed a notice to sell up to 1,803,685 shares of common stock, valued at approximately $134 million, through Charles Schwab & Co., Inc. The proposed sale date is August 5, 2026, on NASDAQ. The …

ADM Q2 Earnings Call Highlights Biofuel-Led Outlook Raise

Archer-Daniels-Midland Company ADM used its second-quarter 2026 earnings call to frame the year around stronger biofuels economics and execution gains across crushing, ethanol and Nutrition. ADM raised its full-year outlook after adjusted earnings and revenue topped the Zacks Consensus Estimate. Management said second-half delivery …

Is Archer Daniels Midland (ADM) Outperforming Other Consumer Staples Stocks This Year?

For those looking to find strong Consumer Staples stocks, it is prudent to search for companies in the group that are outperforming their peers. Archer Daniels Midland (ADM) is a stock that can certainly grab the attention of many investors, but do its recent …

Guardant Health (GH) Sees 48% Growth as Its Cancer Tests Gain Momentum

Guardant Health (NASDAQ:GH) experienced 48% revenue growth year-over-year, driven by increased adoption of its Guardant360 cancer treatment selection test and the Shield colorectal cancer blood test. The company's prospects are further boosted by the FDA approval of Guardant360 Liquid CDx and the American Cancer …

Dimensional Fund Advisors LP Grows Stock Position in StandardAero, Inc. $SARO

Dimensional Fund Advisors LP significantly increased its stake in StandardAero, Inc. by 2,121.2% in the first quarter, acquiring 1.28 million additional shares, resulting in a 0.40% ownership valued at $34.5 million. Other institutional investors also expanded their positions in the company. Despite CEO Russell …

GUARDANT HEALTH INC : PIPER SANDLER RAISES TARGET PRICE TO $193.00 FROM $135.00

Piper Sandler has increased its target price for Guardant Health Inc. (GH.O) shares to $193.00 from $135.00. This news was reported by Reuters on August 4, 2026. The article reiterates that the content reflects only the author's opinion and is not investment advice.

Archer-Daniels-Midland Company Q2 2026 Earnings Call Summary

Archer-Daniels-Midland Company Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Performance beat …

Guardant Health (GH) insider Ian T. Clark plans potential sale of 14,180 shares

Guardant Health (GH) insider Ian T. Clark has filed a Form 144 notice for a proposed sale of 14,180 shares of common stock, valued at approximately $2,253,450.00. The sale is planned for around August 4, 2026, through Charles Schwab & Co., Inc. on NASDAQ. …

GH Q2 Deep Dive: Shield Coverage and Oncology Uptake Drive Strong Revenue Growth

GH Q2 Deep Dive: Shield Coverage and Oncology Uptake Drive Strong Revenue Growth Diagnostics company Guardant Health (NASDAQ:GH) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 44.3% year on year to $335 million. The company's full-year revenue guidance of …

Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open

Guardant Health (GH) has filed a universal shelf registration statement, granting it the flexibility to issue various securities in the future. This move enables the company to raise capital through debt, equity, or hybrid instruments, potentially supporting future financing, acquisitions, or balance sheet adjustments. …

ADM Earnings Up In Q2; Lifts FY26 Outlook

(RTTNews) - Archer-Daniels-Midland Co. (ADM), a food processing and commodities trading corporation, on Tuesday reported higher net income in the second quarter compared with the previous year. For the second quarter, net earnings attributable to the company increased to $908 million from $219 million …

Archer-Daniels-Midland Reports Increase In Q2 Profit

(RTTNews) - Archer-Daniels-Midland (ADM) reported earnings for its second quarter that Increases, from the same period last year The company's bottom line came in at $908 million, or $1.87 per share. This compares with $219 million, or $0.45 per share, last year. Excluding items, …

Is Ardagh Metal Packaging (AMBP) Fairly Valued Following Earnings And Dividend News?

Ardagh Metal Packaging (AMBP) is under investor scrutiny after reporting Q2 and half-year 2026 results and announcing a new dividend. The stock has seen significant price returns, with a 20.91% increase over 90 days and a 35.73% return over one year. While one valuation …

Sharda Cropchem Q1FY27 revenue rises 9%, net profit dips on forex

Sharda Cropchem Limited (NSE:SHARDACROP) Passed Our Checks, And It's About To Pay A ₹9.00 Dividend

Guardant Health Price Target Raised to $180.00/Share From $130.00 by Stifel

Stifel has raised its price target for Guardant Health (NASDAQ:GH) from $130.00 to $180.00 per share. This indicates a significant increase in the analyst's valuation of the company's stock.

SARO shareholder (NYSE: SARO) files Rule 144 to sell 160,000 shares

A shareholder of StandardAero, Inc. (NYSE: SARO) has

The Sharda Cropchem Limited (NSE:SHARDACROP) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Sarda Energy uploads Q1 FY27 earnings call audio recording

GH- Amid Growth Stock Struggles, Stick with this Health Care Play

July was a dreadful month for growth stocks and indexes, with things like the IBD 50 Index and the iShares MSCI USA Momentum Fund (MTUM) off well over 10%. But I still like Guardant Health Inc. (GH), which has only retreated to its 50-day …

SARDAEN: Record PAT and robust EBITDA growth in Q1 FY27, with major expansion plans ahead

Renaissance Technologies LLC Grows Stock Position in Ardagh Metal Packaging S.A. $AMBP

Renaissance Technologies LLC significantly increased its stake in Ardagh Metal Packaging S.A. (NYSE:AMBP) by 31.9% in the first quarter, now owning 2.89 million shares valued at $11.7 million. The company reported strong first-quarter earnings and revenue, surpassing analyst estimates, and declared a quarterly dividend …

Price to earnings forward of Kardan Real Estate Enterprise & Development Ltd. – TASE:KARE

Archer-Daniels-Midland (ADM) Is Down 7.7% After Major Oilseed Crush Expansion And New COO Hire – Has The Bull Case Changed?

In late July 2026, Archer-Daniels-Midland announced a series of investments to expand North American oilseed crush capacity across four U.S. plants, aiming to unlock about 700,000 metric tons of additional annual capacity by 2028–2029 to serve growing renewable fuel and vegetable oil demand. Alongside …

Guardant Health Earnings: Shield Momentum Shows No Signs Of Slowing, Guidance Raised Again

Guardant Health reported strong second-quarter results, with 44% revenue growth and a 50% sequential increase in Shield colorectal cancer screening tests. Following this performance, management raised its full-year revenue guidance to $1.35 billion at the midpoint, marking a 3% increase from previous guidance. This …

Arrowstreet Capital Limited Partnership Grows Stake in Ardagh Metal Packaging S.A. $AMBP

Arrowstreet Capital Limited Partnership increased its stake in Ardagh Metal Packaging S.A. (AMBP) by 28.4% in the first quarter, now owning 3.27 million shares valued at $13.2 million. Other institutional investors also adjusted their positions in the company. Ardagh Metal Packaging reported strong Q1 …

SARDAEN: Q1 FY27 net profit surged, EPS improved, and board approved up to ₹1,000 crore debt raising

Guardant Health (GH) Stock Jumps As Shield Growth Masks Loss Pressure

Guardant Health (GH) stock increased by 6.3% despite widening losses, as Q2 revenue grew 44% to US$335 million, driven significantly by Shield testing, which saw a more than threefold increase in revenue and test volumes. The market is focusing on the growth story and …

Ardagh Metal Packaging Number of Employees 2026 | Employee Count & Headcount Data

Ardagh Metal Packaging SA (AMBP) had 1,707 employees worldwide as of March 2026, marking a 53.4% growth since 2023. The company is actively hiring, with its workforce concentrated in Brazil, the United States, and the United Kingdom, and Finance and Operations being its largest …

Guardant Health, Thursday's Stock Of The Day, Spikes After Hiking 2026 Outlook

Guardant Health is Thursday's IBD Stock Of The Day in a thriving market for colon cancer screening tests. On Friday, Guardant Health stock surged after the company raised full-year outlook after a Q2 revenue beat late Thursday. Several analysts raised price targets on GH …

Guardant Health Leads the Way in Blood-Based Single Cancer Screening

Guardant Health is positioned as a leader in liquid biopsy, offering market-leading platforms in tumor genomic profiling, molecular residual disease (MRD) testing, and colorectal cancer screening. Despite promising markets with multi-billion dollar revenue potential, the company faces early-stage uncertainties regarding payer coverage and guideline …

Guardant Health hits 52-week high after guidance hike

[Rolled newspaper with the headline Quarterly Results] Zerbor Guardant Health (GH [https://seekingalpha.com/symbol/GH]) added nearly 10% at the market open on Friday to hit a new 52-week high after the blood-based cancer test maker reported Q2 2026 revenue well surpassing the consensus and raised its …

Ardagh Metal Packaging S.A. (AMBP) Q2 2024 Earnings Report - Results, Call & Slides

Ardagh Metal Packaging S.A. (AMBP) reported its Q2 2024 earnings, beating analyst EPS estimates with an actual EPS of $0.06 against a consensus of $0.05. However, the company missed revenue expectations, posting $1.26 billion compared to an expected $1.32 billion. The report also includes …

Is Guardant Health Inc (GH) Overvalued After Q2 Earnings Miss? E

Guardant Health Inc (GH) reported a strong Q2 2026 revenue growth of 44% to $335.0 million, driven by oncology and a surging screening division, but net losses widened to $120.1 million due to increased operational expenses. Despite raising 2026 revenue guidance, GuruFocus deems the …

Guardant Health stock rises after guidance hike (GH:NASDAQ)

Guardant Health (GH) stock rose nearly 10% and hit a new 52-week high after reporting Q2 2026 revenue that significantly beat consensus estimates. The blood-based cancer test maker also raised its full-year outlook, with its oncology portfolio growing 38% year-over-year and screening revenue seeing …